Georgetown Lombardi was established in 1970 and received its initial National Cancer Institute designation in 1974. It was designated a Comprehensive Cancer Center, the highest level of certification for cancer centers, in 1990.[3][2]
Research
Lombardi receives over $100 million in grant funding for research purposes.[4][when?] These grants support research initiatives such as the Breast Cancer Research Program, Cancer Prevention and Control Program, Experimental Therapeutics Program, and Molecular Oncology Program. Designated centers at Lombardi include the Ruesch Center for gastrointestinal cancers, the Nina Hyde Center for Breast Cancer Research, the Innovation Center for Biomedical Informatics, the Fisher Center for Hereditary Cancer and Clinical Genomics Research, and the Center for Drug Discovery.[5] The Capital Breast Care Center and the John Theurer Cancer Center are located offsite.[6][7]
References
^"About". lombardi.georgetown.edu. Retrieved December 20, 2017.
^ ab"History". lombardi.georgetown.edu. Retrieved December 20, 2017.